Bruce Gershenhorn

<i>BRAF</i> V600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy

Samuel J. Klempner, Bruce Gershenhorn, Phu N. Tran et al. · Cancer Discovery · 2016 · 84 citations · Full text

Metastasis of lung adenosquamous carcinoma to meningioma: case report with literature review.

Ryan Glass, Supriya R Hukku, Bruce Gershenhorn et al. · PubMed · 2013 · 21 citations · Full text

Adenocarcinoma Metastasis, Systemic Metastases, Tumoral Pathology +13

41 Clinical activity of BIND-014 (docetaxel nanoparticles for injectable suspension) as second-line therapy in patients (pts) with Stage III/IV non-small cell lung cancer

R. Natale, Mark A. Socinski, L. Hart et al. · European Journal of Cancer · 2014 · 16 citations

Nanomedicine, Drug Targeting, Oncology +12

Bridging the gap by providing access to oncology care to rural communities: A hybrid delivery model combining in-person visits with Telehealth.

Chevon Rariy, Lynn Truesdale, Eugene R. Ahn et al. · Journal of Clinical Oncology · 2021 · 12 citations

Family Medicine, Telepsychiatry, Rural Communities +26